Angiogenesis in neurological disorders: a review.

Abstract

Angiogenesis, recruitment of new blood vessels, is an essential component of the metastatic pathway. These vessels provide the principal route by which tumor cells exit the primary tumor site and enter the circulation. For many tumors, the vascular density can provide a prognostic indicator of metastatic potential, with the highly vascular primary tumors having a higher incidence of metastasis than poorly vascular tumors. The discovery and characterization of tumor-derived angiogenesis modulators greatly contributed to our understanding of how tumors regulate angiogenesis. However, although angiogenesis appears to be a rate-limiting event in tumor growth and metastatic dissemination, a direct connection between the induction of angiogenesis and the progression to tumor malignancy is less well understood. In this review, we discuss the observations concerning the modulation of angiogenesis and their implications in various neurological disorders, as well as their potential impact on cancer therapy.

• Authors: Göksemin Acar, Gamze Tanrıöver, Ramazan Demir
• Journal: Neurological research (Neurol Res) Vol. 34 Issue 7 Pg. 627-35 (Sep 2012) ISSN: 1743-1328 [Electronic] England
• PMID: 22889669 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)

Chemical References

• Angiogenesis Inhibitors

Topics

• Angiogenesis Inhibitors (therapeutic use)
• Animals
• Brain Neoplasms (drug therapy, metabolism, pathology)
• Humans
• Neovascularization, Pathologic (drug therapy, metabolism, pathology)
• Nervous System Diseases (drug therapy, metabolism, pathology)